148 related articles for article (PubMed ID: 12542477)
1. Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
García-Suárez J; Krsnik I; Reyes E; De Miguel D; Hernanz N; Barr-Alí M; Burgaleta C
Br J Haematol; 2003 Jan; 120(2):209-16. PubMed ID: 12542477
[TBL] [Abstract][Full Text] [Related]
2. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
3. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjökholm M
Scand J Infect Dis; 1996; 28(3):297-303. PubMed ID: 8863366
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.
Chernobelski P; Lavrenkov K; Rimar D; Riesenberg K; Schlaeffer F; Ariad S; Mermershtain W
Chemotherapy; 2006; 52(4):185-9. PubMed ID: 16675902
[TBL] [Abstract][Full Text] [Related]
6. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
[TBL] [Abstract][Full Text] [Related]
7. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
Erman M; Akova M; Akan H; Korten V; Ferhanoğlu B; Köksal I; Cetinkaya Y; Uzun O; Unal S;
Scand J Infect Dis; 2001; 33(11):827-31. PubMed ID: 11760163
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
10. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
11. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Marie JP; Vekhoff A; Pico JL; Guy H; Andremont A; Richet H
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():57-64. PubMed ID: 9688452
[TBL] [Abstract][Full Text] [Related]
12. Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Jimeno A; Arcediano A; Bazares S; Amador ML; González-Cortijo L; Ciruelos E; Robles L; Castellano D; Paz-Ares L; Lumbreras C; Hornedo J; Cortés-Funes H
Clin Transl Oncol; 2006 Dec; 8(12):889-95. PubMed ID: 17169762
[TBL] [Abstract][Full Text] [Related]
13. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
14. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
16. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
[TBL] [Abstract][Full Text] [Related]
18. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).
Hann I; Viscoli C; Paesmans M; Gaya H; Glauser M
Br J Haematol; 1997 Dec; 99(3):580-8. PubMed ID: 9401070
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection.
Cherif H; Axdorph U; Kalin M; Björkholm M
Scand J Infect Dis; 2013 Feb; 45(2):112-6. PubMed ID: 22992038
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
